Literature DB >> 26248382

Key Residues of Outer Membrane Protein OprI Involved in Hexamer Formation and Bacterial Susceptibility to Cationic Antimicrobial Peptides.

Ting-Wei Chang1, Chiu-Feng Wang1, Hsin-Jye Huang1, Iren Wang2, Shang-Te Danny Hsu2, You-Di Liao3.   

Abstract

Antimicrobial peptides (AMPs) are important components of the host innate defense mechanism against invading pathogens. Our previous studies have shown that the outer membrane protein, OprI from Pseudomonas aeruginosa or its homologue, plays a vital role in the susceptibility of Gram-negative bacteria to cationic α-helical AMPs (Y. M. Lin, S. J. Wu, T. W. Chang, C. F. Wang, C. S. Suen, M. J. Hwang, M. D. Chang, Y. T. Chen, Y. D. Liao, J Biol Chem 285:8985-8994, 2010, http://dx.doi.org/10.1074/jbc.M109.078725; T. W. Chang, Y. M. Lin, C. F. Wang, Y. D. Liao, J Biol Chem 287:418-428, 2012, http://dx.doi.org/10.1074/jbc.M111.290361). Here, we obtained two forms of recombinant OprI: rOprI-F, a hexamer composed of three disulfide-bridged dimers, was active in AMP binding, while rOprI-R, a trimer, was not. All the subunits predominantly consisted of α-helices and exhibited rigid structures with a melting point centered around 76°C. Interestingly, OprI tagged with Escherichia coli signal peptide was expressed in a hexamer, which was anchored on the surface of E. coli, possibly through lipid acids added at the N terminus of OprI and involved in the binding and susceptibility to AMP as native P. aeruginosa OprI. Deletion and mutation studies showed that Cys1 and Asp27 played a key role in hexamer formation and AMP binding, respectively. The increase of OprI hydrophobicity upon AMP binding revealed that it undergoes conformational changes for membrane fusion. Our results showed that OprI on bacterial surfaces is responsible for the recruitment and susceptibility to amphipathic α-helical AMPs and may be used to screen antimicrobials.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26248382      PMCID: PMC4576038          DOI: 10.1128/AAC.01406-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations.

Authors:  Afonso P Basto; João Piedade; Ruben Ramalho; Susana Alves; Helena Soares; Pierre Cornelis; Carlos Martins; Alexandre Leitão
Journal:  J Biotechnol       Date:  2011-11-18       Impact factor: 3.307

Review 2.  Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides.

Authors:  Pierre Nicolas
Journal:  FEBS J       Date:  2009-10-09       Impact factor: 5.542

Review 3.  The expanding scope of antimicrobial peptide structures and their modes of action.

Authors:  Leonard T Nguyen; Evan F Haney; Hans J Vogel
Journal:  Trends Biotechnol       Date:  2011-06-15       Impact factor: 19.536

4.  Trimeric structure and localization of the major lipoprotein in the cell surface of Escherichia coli.

Authors:  D S Choi; H Yamada; T Mizuno; S Mizushima
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

5.  Post-translational modification and processing of Escherichia coli prolipoprotein in vitro.

Authors:  M Tokunaga; H Tokunaga; H C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Interaction of 8-amino-1-naphthalenesulfonate with rod outer segment membrane.

Authors:  U P Andley; B Chakrabarti
Journal:  Biochemistry       Date:  1981-03-17       Impact factor: 3.162

7.  Outer membrane lipoprotein Lpp is Gram-negative bacterial cell surface receptor for cationic antimicrobial peptides.

Authors:  Ting-Wei Chang; Yu-Ming Lin; Chiu-Feng Wang; You-Di Liao
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

8.  Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.

Authors:  M Duchêne; C Barron; A Schweizer; B U von Specht; H Domdey
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

9.  Isolation of characterization of a major outer membrane protein of Pseudomonas aeruginosa. Evidence for the occurrence of a lipoprotein.

Authors:  T Mizuno; M Kageyama
Journal:  J Biochem       Date:  1979-01       Impact factor: 3.387

10.  The free and bound forms of Lpp occupy distinct subcellular locations in Escherichia coli.

Authors:  Charles E Cowles; Yongfeng Li; Martin F Semmelhack; Ileana M Cristea; Thomas J Silhavy
Journal:  Mol Microbiol       Date:  2011-01-24       Impact factor: 3.501

View more
  7 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin.

Authors:  Hung-Mu Wei; Li-Chih Lin; Chiu-Feng Wang; Yi-Jang Lee; Yuan-Tsong Chen; You-Di Liao
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

3.  Sarkosyl-Induced Helical Structure of an Antimicrobial Peptide GW-Q6 Plays an Essential Role in the Binding of Surface Receptor OprI in Pseudomonas aeruginosa.

Authors:  Tien-Sheng Tseng; Shih-Han Wang; Ting-Wei Chang; Hung-Mu Wei; Yu-June Wang; Keng-Chang Tsai; You-Di Liao; Chinpan Chen
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

4.  Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.

Authors:  Ting-Wei Chang; Shu-Yi Wei; Shih-Han Wang; Hung-Mu Wei; Yu-June Wang; Chiu-Feng Wang; Chinpan Chen; You-Di Liao
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

5.  Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.

Authors:  Feng Yang; Jiang Gu; Liuyang Yang; Chen Gao; Haiming Jing; Ying Wang; Hao Zeng; Quanming Zou; Fenglin Lv; Jinyong Zhang
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

6.  Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model.

Authors:  Mohammad Hadi Fakoor; Seyed Latif Mousavi Gargari; Parviz Owlia; Azar Sabokbar
Journal:  Infect Drug Resist       Date:  2020-06-09       Impact factor: 4.003

7.  Oligomerization and insertion of antimicrobial peptide TP4 on bacterial membrane and membrane-mimicking surfactant sarkosyl.

Authors:  Shih-Han Wang; Chiu-Feng Wang; Ting-Wei Chang; Yu-June Wang; You-Di Liao
Journal:  PLoS One       Date:  2019-05-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.